Hepatic senescence, the good and the bad

Nazmul Huda, Gang Liu, Honghai Hong, Shengmin Yan, Bilon Khambu, Xiao-Ming Yin

Research output: Contribution to journalReview article

Abstract

Gradual alterations of cell's physiology and functions due to age or exposure to various stresses lead to the conversion of normal cells to senescent cells. Once becoming senescent, the cell stops dividing permanently but remains metabolically active. Cellular senescence does not have a single marker but is characterized mainly by a combination of multiple markers, such as, morphological changes, expression of cell cycle inhibitors, senescence associated â-galactosidase activity, and changes in nuclear membrane. When cells in an organ become senescent, the entire organism can be affected. This may occur through the senescence-associated secretory phenotype (SASP). SASP may exert beneficial or harmful effects on the microenvironment of tissues. Research on senescence has become a very exciting field in cell biology since the link between age-related diseases, including cancer, and senescence has been established. The loss of regenerative and homeostatic capacity of the liver over the age is somehow connected to cellular senescence. The major contributors of senescence properties in the liver are hepatocytes and cholangiocytes. Senescent cells in the liver have been implicated in the etiology of chronic liver diseases including cirrhosis and hepatocellular carcinoma and in the interference of liver regeneration. This review summarizes recently reported findings in the understanding of the molecular mechanisms of senescence and its relationship with liver diseases.

Original languageEnglish (US)
Pages (from-to)5069-5081
Number of pages13
JournalWorld Journal of Gastroenterology
Volume25
Issue number34
DOIs
StatePublished - Sep 14 2019

Fingerprint

Liver
Cell Aging
Liver Diseases
Galactosidases
Phenotype
Cell Physiological Phenomena
Liver Regeneration
Nuclear Envelope
Cell Biology
Hepatocytes
Hepatocellular Carcinoma
Cell Cycle
Fibrosis
Chronic Disease
Research
Neoplasms

Keywords

  • Cell cycle arrest
  • Cholangiocyte
  • DNA damage
  • Hepatic stellate cell
  • Hepatocyte
  • Senescence
  • Senescence associated secretory phenotype

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Hepatic senescence, the good and the bad. / Huda, Nazmul; Liu, Gang; Hong, Honghai; Yan, Shengmin; Khambu, Bilon; Yin, Xiao-Ming.

In: World Journal of Gastroenterology, Vol. 25, No. 34, 14.09.2019, p. 5069-5081.

Research output: Contribution to journalReview article

Huda, Nazmul ; Liu, Gang ; Hong, Honghai ; Yan, Shengmin ; Khambu, Bilon ; Yin, Xiao-Ming. / Hepatic senescence, the good and the bad. In: World Journal of Gastroenterology. 2019 ; Vol. 25, No. 34. pp. 5069-5081.
@article{c0653fbf23e546b9b86de6f712c41cc4,
title = "Hepatic senescence, the good and the bad",
abstract = "Gradual alterations of cell's physiology and functions due to age or exposure to various stresses lead to the conversion of normal cells to senescent cells. Once becoming senescent, the cell stops dividing permanently but remains metabolically active. Cellular senescence does not have a single marker but is characterized mainly by a combination of multiple markers, such as, morphological changes, expression of cell cycle inhibitors, senescence associated {\^a}-galactosidase activity, and changes in nuclear membrane. When cells in an organ become senescent, the entire organism can be affected. This may occur through the senescence-associated secretory phenotype (SASP). SASP may exert beneficial or harmful effects on the microenvironment of tissues. Research on senescence has become a very exciting field in cell biology since the link between age-related diseases, including cancer, and senescence has been established. The loss of regenerative and homeostatic capacity of the liver over the age is somehow connected to cellular senescence. The major contributors of senescence properties in the liver are hepatocytes and cholangiocytes. Senescent cells in the liver have been implicated in the etiology of chronic liver diseases including cirrhosis and hepatocellular carcinoma and in the interference of liver regeneration. This review summarizes recently reported findings in the understanding of the molecular mechanisms of senescence and its relationship with liver diseases.",
keywords = "Cell cycle arrest, Cholangiocyte, DNA damage, Hepatic stellate cell, Hepatocyte, Senescence, Senescence associated secretory phenotype",
author = "Nazmul Huda and Gang Liu and Honghai Hong and Shengmin Yan and Bilon Khambu and Xiao-Ming Yin",
year = "2019",
month = "9",
day = "14",
doi = "10.3748/wjg.v25.i34.5069",
language = "English (US)",
volume = "25",
pages = "5069--5081",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "34",

}

TY - JOUR

T1 - Hepatic senescence, the good and the bad

AU - Huda, Nazmul

AU - Liu, Gang

AU - Hong, Honghai

AU - Yan, Shengmin

AU - Khambu, Bilon

AU - Yin, Xiao-Ming

PY - 2019/9/14

Y1 - 2019/9/14

N2 - Gradual alterations of cell's physiology and functions due to age or exposure to various stresses lead to the conversion of normal cells to senescent cells. Once becoming senescent, the cell stops dividing permanently but remains metabolically active. Cellular senescence does not have a single marker but is characterized mainly by a combination of multiple markers, such as, morphological changes, expression of cell cycle inhibitors, senescence associated â-galactosidase activity, and changes in nuclear membrane. When cells in an organ become senescent, the entire organism can be affected. This may occur through the senescence-associated secretory phenotype (SASP). SASP may exert beneficial or harmful effects on the microenvironment of tissues. Research on senescence has become a very exciting field in cell biology since the link between age-related diseases, including cancer, and senescence has been established. The loss of regenerative and homeostatic capacity of the liver over the age is somehow connected to cellular senescence. The major contributors of senescence properties in the liver are hepatocytes and cholangiocytes. Senescent cells in the liver have been implicated in the etiology of chronic liver diseases including cirrhosis and hepatocellular carcinoma and in the interference of liver regeneration. This review summarizes recently reported findings in the understanding of the molecular mechanisms of senescence and its relationship with liver diseases.

AB - Gradual alterations of cell's physiology and functions due to age or exposure to various stresses lead to the conversion of normal cells to senescent cells. Once becoming senescent, the cell stops dividing permanently but remains metabolically active. Cellular senescence does not have a single marker but is characterized mainly by a combination of multiple markers, such as, morphological changes, expression of cell cycle inhibitors, senescence associated â-galactosidase activity, and changes in nuclear membrane. When cells in an organ become senescent, the entire organism can be affected. This may occur through the senescence-associated secretory phenotype (SASP). SASP may exert beneficial or harmful effects on the microenvironment of tissues. Research on senescence has become a very exciting field in cell biology since the link between age-related diseases, including cancer, and senescence has been established. The loss of regenerative and homeostatic capacity of the liver over the age is somehow connected to cellular senescence. The major contributors of senescence properties in the liver are hepatocytes and cholangiocytes. Senescent cells in the liver have been implicated in the etiology of chronic liver diseases including cirrhosis and hepatocellular carcinoma and in the interference of liver regeneration. This review summarizes recently reported findings in the understanding of the molecular mechanisms of senescence and its relationship with liver diseases.

KW - Cell cycle arrest

KW - Cholangiocyte

KW - DNA damage

KW - Hepatic stellate cell

KW - Hepatocyte

KW - Senescence

KW - Senescence associated secretory phenotype

UR - http://www.scopus.com/inward/record.url?scp=85072308963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072308963&partnerID=8YFLogxK

U2 - 10.3748/wjg.v25.i34.5069

DO - 10.3748/wjg.v25.i34.5069

M3 - Review article

C2 - 31558857

AN - SCOPUS:85072308963

VL - 25

SP - 5069

EP - 5081

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 34

ER -